IP Library Granted Patent US 8,956,442
Granted Patent B2
US 8,956,442 · App. 12/416,253 · Granted Feb 17, 2015

Devices and methods for improvement of microvascular function

Inventors: Dan Allan Robert Kristensson (Ängelholm, SE); Jan Åke Allen Kristensson (Ängelholm, SE); Pål Martin Svensson (Halmstad, SE)
Assignee: Airsonett AB
F24F3/1607G06Q30/0241
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,956,442
App. No.
12/416,253
Granted
Feb 17, 2015
Kind
B2
Abstract

Provided are methods and devices for improving microvascular function in humans and mammals. Reduction of exposure to airborne fine particles using air treatment systems increases microvascular function in persons at cardiovascular risk. Preferred treatment systems provide a zone of clean air having >75% reduction in airborne particle counts around a person at cardiovascular risk. The devices and methods can be optimally used during sleep, when the user is stationary for an extended period.

Claims (11)

1. A method of treating a user comprising the steps of:

increasing the user's microvascular function by at least 5% after 48 hours by;

applying the method to a non-smoking human during periods of sleep,

reducing the user's inhaled exposure to airborne fine particles by generating a clean air zone around the user by indoor air filtration, which results in a reduction in the airborne fine particle count of more than 95% as measured in the clean air zone when compared to ambient air, and

causing air in the clean air zone to descend at a velocity resulting from maintaining the air temperature of the air deployed into the clean air zone at a temperature range of between 0.3 to 3.0 degrees C. cooler than the ambient air surrounding the clean air zone,

such that the descending air descends in a laminar fashion which substantially prevents in-mixing of ambient air, which prevents the user from being exposed to an unpleasant draft and substantially prevents airborne particles from the ambient air to increase the airborne particle count of the air in the clean air zone.

2. A method according to claim 1 , wherein the user is a person at cardiovascular risk.

3. A method according to claim 1 , wherein the clean air zone is limited to the head area of the user.

4. A method according to claim 1 , including applying the method for at least 6 hours daily and for an extended period of at least 6 months.

5. A method according to claim 1 , including driving the cool clean air by a minimal impulse sufficient only to overcome resistance in relation to discharge of clean air.

6. A method according to claim 1 , including driving the cooled clean air by a minimal impulse sufficient only to overcome resistance in relation to discharge of clean air.

Assignments (3)
CHANGE OF NAME Recorded Feb 22, 2013
From: AIRSONETT HOMECARE AB (556893-9577)
To: AIRSONETT AB (556823-9577)
Reel/Frame 029860/0585 →
CONFIRMATION ASSIGNMENT Recorded Feb 20, 2013
From: AIRSONETT AB (556593-8775)
To: AIRSONETT HOMECARE AB (556893-9577)
Reel/Frame 029839/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2009
From: KRISTENSSON, DAN ALLAN ROBERT; KRISTENSSON, JAN AAKE ALLAN; SVENSSON, PAAL MARTIN
To: AIRSONETT AB
Reel/Frame 022822/0560 →
Continuity (2)
Provisional Application 61041252 · Apr 1, 2008
Related Publication 20090247065A1 · Oct 1, 2009